微盘股

Search documents
佳创视讯涨2.14%,成交额1.30亿元,主力资金净流入661.89万元
Xin Lang Cai Jing· 2025-09-09 07:24
Company Overview - Jiachuan Video Technology Co., Ltd. is located in Shenzhen, Guangdong Province, and was established on October 22, 2000. The company was listed on September 16, 2011. Its main business includes software system products, system integration, and terminal products [2]. - The revenue composition of the company is as follows: 84.87% from system integration and services, and 15.13% from audio and video software products and solutions [2]. Stock Performance - As of September 9, Jiachuan Video's stock price increased by 2.14%, reaching 6.20 CNY per share, with a trading volume of 1.30 billion CNY and a turnover rate of 5.77%. The total market capitalization is 2.671 billion CNY [1]. - Year-to-date, the stock price has risen by 15.03%. However, it has decreased by 0.80% in the last five trading days and by 7.05% over the past 20 days, while it has increased by 6.90% over the last 60 days [2]. Financial Performance - For the first half of 2025, Jiachuan Video reported a revenue of 82.0162 million CNY, representing a year-on-year growth of 23.16%. However, the net profit attributable to the parent company was -7.4256 million CNY, which is a year-on-year increase of 71.13% in losses [2]. - The company has distributed a total of 52.122 million CNY in dividends since its A-share listing, but there have been no dividends distributed in the last three years [3]. Shareholder Information - As of June 30, 2025, the number of shareholders is 34,700, a decrease of 12.92% from the previous period. The average number of circulating shares per person is 10,674, which has increased by 14.84% [2]. - Among the top ten circulating shareholders, the Dazheng CSI 360 Internet + Index A (002236) is the seventh largest shareholder, holding 2.3722 million shares as a new shareholder [3].
天益医疗涨2.08%,成交额393.43万元
Xin Lang Cai Jing· 2025-09-08 02:32
责任编辑:小浪快报 截至6月30日,天益医疗股东户数4196.00,较上期减少0.31%;人均流通股4372股,较上期增加0.31%。 2025年1月-6月,天益医疗实现营业收入2.27亿元,同比增长11.50%;归母净利润948.32万元,同比减少 35.23%。 分红方面,天益医疗A股上市后累计派现1.02亿元。近三年,累计派现8749.78万元。 机构持仓方面,截止2025年6月30日,天益医疗十大流通股东中,鹏华弘嘉混合A(003165)位居第四 大流通股东,持股49.87万股,持股数量较上期不变。圆信永丰聚优A(010469)位居第八大流通股东, 持股28.70万股,相比上期减少2.80万股。圆信永丰医药健康A(006274)位居第十大流通股东,持股 23.00万股,相比上期减少4.55万股。鹏华优质治理混合(LOF)A(160611)退出十大流通股东之列。 9月8日,天益医疗盘中上涨2.08%,截至09:48,报45.14元/股,成交393.43万元,换手率0.48%,总市值 26.61亿元。 天益医疗今年以来股价涨25.00%,近5个交易日涨2.13%,近20日跌4.73%,近60日涨15.71 ...
力合微涨2.01%,成交额7154.26万元,主力资金净流入572.06万元
Xin Lang Cai Jing· 2025-09-05 06:21
Group 1 - The core viewpoint of the news highlights the recent stock performance and financial metrics of Lihua Microelectronics, indicating a mixed trend in its stock price and financial results [1][2]. - As of September 5, Lihua Micro's stock price increased by 2.01% to 22.85 CNY per share, with a total market capitalization of 3.32 billion CNY [1]. - The company experienced a net inflow of main funds amounting to 5.72 million CNY, with significant buying activity from large orders [1]. Group 2 - For the first half of 2025, Lihua Micro reported a revenue of 198 million CNY, reflecting a year-on-year decrease of 24.74%, and a net profit attributable to shareholders of 24.85 million CNY, down 41.15% year-on-year [2]. - The number of shareholders decreased by 5.22% to 11,100, while the average circulating shares per person increased by 26.54% to 13,110 shares [2]. - Since its A-share listing, Lihua Micro has distributed a total of 131 million CNY in dividends, with 96.43 million CNY distributed over the past three years [3].
万隆光电涨2.03%,成交额3578.48万元,主力资金净流入153.55万元
Xin Lang Cai Jing· 2025-09-05 04:16
Company Overview - Wanlong Optoelectronics is located in Xiaoshan District, Hangzhou, Zhejiang Province, and was established on May 13, 2001. The company was listed on October 19, 2017. Its main business includes the research, production, sales, and technical services of broadcasting network equipment and data communication systems [1][2]. Financial Performance - For the first half of 2025, Wanlong Optoelectronics achieved operating revenue of 125 million yuan, a year-on-year decrease of 28.55%. The net profit attributable to the parent company was -14 million yuan, a year-on-year decrease of 260.29% [2]. - Since its A-share listing, the company has distributed a total of 22.64 million yuan in dividends, with no dividends distributed in the past three years [3]. Stock Performance - As of September 5, Wanlong Optoelectronics' stock price increased by 2.03%, reaching 19.08 yuan per share, with a total market capitalization of 1.898 billion yuan. The stock has seen a year-to-date increase of 6.83%, but has declined by 5.96% over the past five trading days, 7.92% over the past 20 days, and 5.17% over the past 60 days [1]. - The stock's trading volume on September 5 was 35.7848 million yuan, with a turnover rate of 2.56% [1]. Shareholder Information - As of June 30, 2025, the number of shareholders of Wanlong Optoelectronics was 9,776, a decrease of 6.59% from the previous period. The average number of circulating shares per person was 7,628, a decrease of 0.81% [2]. - Among the top ten circulating shareholders, the Dazheng Zhongzheng 360 Internet + Index A (002236) has exited the list as of June 30, 2025 [3]. Industry Classification - Wanlong Optoelectronics belongs to the communication industry, specifically in the communication equipment sector, focusing on communication network devices and components. The company is also associated with concepts such as micro-cap stocks, small-cap stocks, Pinduoduo concept, RCS concept, and broadcasting systems [2].
中达安跌2.25%,成交额1351.29万元,主力资金净流出169.56万元
Xin Lang Cai Jing· 2025-09-05 03:15
Company Overview - Zhongda An's stock price decreased by 2.25% on September 5, trading at 13.45 CNY per share with a total market capitalization of 1.885 billion CNY [1] - The company has seen a year-to-date stock price increase of 37.39%, but has experienced a decline of 2.39% over the last five trading days and 5.01% over the last twenty days [1] - Zhongda An's main business includes project management services, primarily engineering supervision, with revenue contributions from various sectors such as power supervision (20.73%), civil engineering supervision (19.72%), and consulting and agency services (18.20%) [1] Financial Performance - As of June 30, Zhongda An reported a total of 15,100 shareholders, an increase of 41.65% from the previous period [2] - For the first half of 2025, the company achieved operating revenue of 302 million CNY, a year-on-year decrease of 8.48%, and a net profit attributable to shareholders of 1.8478 million CNY, down 59.99% year-on-year [2] - The company has distributed a total of 30.3829 million CNY in dividends since its A-share listing, with 1.3632 million CNY distributed over the last three years [3] Market Activity - The net outflow of main funds was 1.6956 million CNY, with large single purchases accounting for 13.41% and sales for 25.96% of the total [1] - The trading volume on September 5 was 13.5129 million CNY, with a turnover rate of 0.82% [1] Industry Classification - Zhongda An is classified under the construction decoration industry, specifically in engineering consulting services [1]
我乐家居跌2.06%,成交额616.74万元
Xin Lang Cai Jing· 2025-09-05 03:14
Company Overview - Iole Home is located in Jiangning Economic and Technological Development Zone, Nanjing, Jiangsu Province, and was established on June 19, 2006. The company was listed on June 16, 2017. Its main business involves the design, research and development, production, sales, and related services of overall kitchen cabinets and whole-house custom furniture [1] - The revenue composition of Iole Home is 82.18% from whole-house customization and 17.82% from overall kitchen cabinets [1] Stock Performance - As of September 5, Iole Home's stock price was 8.56 CNY per share, with a market capitalization of 2.732 billion CNY. The stock has increased by 52.31% year-to-date, but has seen a decline of 2.39% over the last five trading days and 5.93% over the last twenty days [1] - The stock has appeared on the "Dragon and Tiger List" three times this year, with the most recent appearance on June 4, where it recorded a net buy of -20.35 million CNY [1] Financial Performance - For the first half of 2025, Iole Home achieved an operating income of 669 million CNY, representing a year-on-year growth of 1.80%. The net profit attributable to shareholders was 92.31 million CNY, showing a significant year-on-year increase of 103.18% [2] - Since its A-share listing, Iole Home has distributed a total of 514 million CNY in dividends, with 295 million CNY distributed over the past three years [3] Shareholder Information - As of June 30, 2025, Iole Home had 12,300 shareholders, a decrease of 10.09% from the previous period. The average number of circulating shares per person increased by 11.22% to 25,865 shares [2] - Among the top ten circulating shareholders, the fund "China Europe Value Select Mixed A" (166019) ranked as the eighth largest shareholder, holding 1.3607 million shares, a decrease of 1.3872 million shares compared to the previous period [3]
维业股份跌2.11%,成交额709.02万元
Xin Lang Cai Jing· 2025-09-05 02:15
Company Overview - Viyang Group Co., Ltd. is located in Shenzhen, Guangdong Province, and was established on October 18, 1994. The company was listed on March 16, 2017. Its main business involves the design and construction of building decoration projects [1] - The revenue composition of Viyang Group is as follows: decoration construction 60.47%, civil construction 38.67%, other (supplementary) 0.45%, and decoration design 0.42% [1] Stock Performance - As of September 5, Viyang's stock price decreased by 2.11%, trading at 8.83 yuan per share, with a total market capitalization of 1.837 billion yuan. The trading volume was 7.0902 million yuan, and the turnover rate was 0.39% [1] - Year-to-date, Viyang's stock price has declined by 7.05%. In the last five trading days, it fell by 1.67%, and over the past 20 days, it decreased by 7.44%. However, in the last 60 days, the stock price increased by 3.76% [1] Financial Performance - For the first half of 2025, Viyang Group reported a revenue of 4.008 billion yuan, a year-on-year decrease of 47.81%. The net profit attributable to shareholders was 10.4334 million yuan, reflecting a year-on-year increase of 5.38% [1] - Since its A-share listing, Viyang has distributed a total of 62.1497 million yuan in dividends, with 4.1611 million yuan distributed over the past three years [2] Shareholder Information - As of June 30, 2025, Viyang Group had 13,200 shareholders, a decrease of 6.73% from the previous period. The average number of circulating shares per shareholder was 15,359, an increase of 10.68% [1] - Among the top ten circulating shareholders, the Noan Multi-Strategy Mixed A fund (320016) is the newest shareholder, holding 1.1606 million shares [2]
森泰股份跌2.05%,成交额446.04万元
Xin Lang Cai Jing· 2025-09-05 02:15
Core Viewpoint - SenTai Co., Ltd. has experienced a stock price decline of 2.05% on September 5, 2023, with a current share price of 18.63 yuan, reflecting a total market capitalization of 2.202 billion yuan. The company has seen a year-to-date stock price increase of 22.57% but has faced a decline of 2.41% over the past five trading days and 9.39% over the past 20 days [1]. Company Overview - SenTai Co., Ltd. was established on December 15, 2006, and went public on April 17, 2023. The company is located in Guangde Economic Development Zone, Xuancheng City, Anhui Province. Its main business involves the research, design, production, and sales of high-performance wood-plastic composite materials and new stone-wood plastic composite materials [1]. - The revenue composition of SenTai Co., Ltd. is as follows: high-performance wood-plastic composite products account for 60.56%, new stone-wood plastic composite products for 34.75%, other products for 3.85%, prefabricated buildings for 0.73%, and other supplementary products for 0.10% [1]. Financial Performance - For the period from January to June 2025, SenTai Co., Ltd. achieved an operating income of 503 million yuan, representing a year-on-year growth of 20.96%. However, the net profit attributable to the parent company was 31.1848 million yuan, showing a year-on-year decrease of 19.97% [1]. - As of June 30, 2025, the company has distributed a total of 100 million yuan in dividends since its A-share listing [2]. Shareholder Information - As of June 30, 2025, the number of shareholders in SenTai Co., Ltd. was 8,540, a decrease of 2.89% from the previous period. The average number of circulating shares per person increased by 2.97% to 5,157 shares [1]. - Notably, the seventh largest circulating shareholder is the Noan Multi-Strategy Mixed A fund, holding 555,100 shares as a new shareholder, while the China Securities 500 Equal Weight Index Enhanced A fund has exited the top ten circulating shareholders list [2].
皮阿诺跌2.02%,成交额508.38万元
Xin Lang Cai Jing· 2025-09-05 02:13
Group 1 - The stock price of PIANO fell by 2.02% on September 5, reaching 11.65 CNY per share, with a total market capitalization of 2.131 billion CNY [1] - Year-to-date, PIANO's stock price has increased by 6.20%, but it has seen declines of 2.59% over the last five trading days, 10.52% over the last 20 days, and 11.47% over the last 60 days [1] - PIANO has appeared on the trading leaderboard once this year, with the most recent occurrence on May 12, where it recorded a net buy of -4.2408 million CNY [1] Group 2 - As of June 30, PIANO had 10,600 shareholders, an increase of 7.05% from the previous period, while the average circulating shares per person decreased by 9.15% to 12,166 shares [2] - For the first half of 2025, PIANO reported revenue of 268 million CNY, a year-on-year decrease of 40.65%, and a net profit attributable to shareholders of -12.5764 million CNY, down 381.84% year-on-year [2] Group 3 - Since its A-share listing, PIANO has distributed a total of 198 million CNY in dividends, with 36.5832 million CNY distributed over the past three years [3]
港通医疗涨0.47%,成交额3360.51万元,后市是否有机会?
Xin Lang Cai Jing· 2025-09-04 08:08
Core Viewpoint - The company, Sichuan Portong Medical Equipment Group Co., Ltd., is engaged in the medical device industry, focusing on providing medical gas systems and clean operating room solutions for healthcare institutions. The company has recently experienced fluctuations in stock performance and financial metrics, indicating potential investment opportunities and challenges. Company Overview - Sichuan Portong Medical Equipment Group was established on January 13, 1998, and went public on July 25, 2023. The company is headquartered in Chengdu, Sichuan Province, and specializes in medical professional engineering solutions, primarily in medical gas systems and clean operating rooms [7]. Financial Performance - For the first half of 2023, the company reported revenue of 265 million yuan, a year-on-year decrease of 39.29%. The net profit attributable to the parent company was -8.4044 million yuan, reflecting a year-on-year decline of 154.53% [8]. - The company has distributed a total of 48.9973 million yuan in dividends since its A-share listing [9]. Market Activity - On September 4, the stock price of Portong Medical increased by 0.47%, with a trading volume of 33.6051 million yuan and a turnover rate of 2.49%. The total market capitalization stands at 2.129 billion yuan [1]. - The stock has seen a net outflow of 2.3291 million yuan from major investors today, with a ranking of 64 out of 131 in its industry [4]. Product and Technology Development - The company has developed the Portong Cloud Monitoring Platform, which utilizes advanced IoT technology and online cloud monitoring to provide real-time monitoring solutions for medical equipment in hospitals [3]. - Portong Medical has obtained various licenses and certifications for the production and operation of medical devices, including Class I and II medical device production licenses and operating permits [2]. Strategic Initiatives - The company plans to repurchase shares with a total fund amounting to no less than 50 million yuan and no more than 100 million yuan, with a maximum price of 28.49 yuan per share. The funding will come from its own resources and a special loan from Bank of China [3]. - Portong Medical has been recognized as a "specialized, refined, distinctive, and innovative" small giant enterprise, which is a prestigious title for small and medium-sized enterprises in China, indicating its strong market position and innovation capabilities [3].